Bell John K 4
4 · DelMar Pharmaceuticals, Inc. · Filed Nov 13, 2018
Insider Transaction Report
Form 4
Bell John K
Director
Transactions
- Award
Options (Right to Buy)
2018-11-08+40,000→ 40,000 totalExercise: $0.61Exp: 2028-11-08→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in twelve (12) equal monthly installments beginning on December 8, 2018.